Latest News
AEye Surges on Analyst Upgrade as Lidar Turnaround Hopes Grow
AEye surged over 30% after Craig-Hallum initiated coverage with a buy rating and $3.50 target, spotlighting a potential turnaround. The lidar maker faces revenue challenges but adds new operations head.
Nasdaq Hits Record as Intel AI Outlook Fuels Chip Rally, Dow Dips
The Nasdaq hit a new intraday high Friday as Intel's strong Q2 outlook sparked a broad chip rally, while the Dow slipped. Consumer sentiment hit a record low, keeping inflation worries front and center.
Snowflake Shares Tumble as AI Initiatives Face Software Sector Headwinds
Snowflake shares dropped 5.5% to $138.42, pressured by a software sector selloff and a class-action deadline. The company is expanding its AI offerings, but investors remain cautious about AI's effect on revenue.
Eos Energy Q1 Earnings Set for May 13 After Revenue Preview, EOSE Stock Surges
Eos Energy Enterprises will report Q1 results on May 13 after previewing $56M-$57M revenue and 17% shipment growth. Shares rose 12% on AI power deal with TURBINE-X.
Charter Communications Shares Tumble 22% as Broadband Losses Double
Charter Communications shares fell 22% after reporting 120,000 broadband customer losses in Q1, double last year's figure and worse than analyst expectations.
Lilly's Oral Obesity Drug Foundayo Trails Novo Nordisk's Wegovy in Early Prescription Data
Eli Lilly's Foundayo prescriptions hit 3,707 in week two, well behind Novo Nordisk's Wegovy. Lilly shares dropped 4%, while Novo gained 6%. Analysts advise caution on early figures.
Cheetah Net Soars on Acquisition Deal, Heavy Trading Volume
Cheetah Net shares jumped on heavy volume after agreeing to buy Super International Trading for $4.98M in cash, with a $10M annual revenue target.
Keel Infrastructure Sells Paraguay Site for $13M, Exits Latin America
Keel Infrastructure sold its Paraguay facility for $13M, less than half the original price, completing its Latin American exit and shift toward AI data centers.
Tempus AI Partners with USC Health System, Unlocking Access to 1.5 Million Annual Visits
Tempus AI Inc. partners with USC's Keck School of Medicine to deploy its molecular testing and trial-matching platform across a health system seeing 1.5 million patient visits each year.
FreeCast Soars on DIRECTV Multifamily Deal, Financing Risks Remain
FreeCast shares jumped 23.8% on a DIRECTV multifamily deal. Maxim Group initiated with Buy and $6 target. Dilution risks persist per SEC filings.
Novo Nordisk Wegovy Pill Prescriptions Surge Past Eli Lilly's Foundayo in Early Launch Race
Novo Nordisk's Wegovy pill recorded 18,410 U.S. prescriptions in its second week, far outpacing Eli Lilly's Foundayo at 3,707, according to IQVIA data. Novo shares rose, Lilly fell.
